Victory Capital Management Inc Repligen Corp Transaction History

Victory Capital Management Inc

  • $95.8 Billion
  • Q2 2024

A detailed history of Victory Capital Management Inc transactions in Repligen Corp stock. As of the latest transaction made, Victory Capital Management Inc holds 19,188 shares of RGEN stock, worth $2.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,188
Previous 24,513 21.72%
Holding current value
$2.8 Million
Previous $4.51 Million 46.36%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024
SELL
$120.0 - $182.95 $639,000 - $974,208
-5,325 Reduced 21.72%
19,188 $2.42 Million
Q1 2024

May 03, 2024
BUY
$170.78 - $208.42 $553,668 - $675,697
3,242 Added 15.24%
24,513 $4.51 Million
Q4 2023

Feb 05, 2024
BUY
$114.17 - $185.35 $211,328 - $343,082
1,851 Added 9.53%
21,271 $3.82 Million
Q3 2023

Nov 06, 2023
BUY
$138.78 - $176.51 $586,761 - $746,284
4,228 Added 27.83%
19,420 $3.09 Million
Q2 2023

Jul 27, 2023
SELL
$138.42 - $180.31 $560,877 - $730,616
-4,052 Reduced 21.06%
15,192 $2.15 Million
Q1 2023

May 02, 2023
SELL
$154.26 - $198.1 $2.95 Million - $3.79 Million
-19,118 Reduced 49.84%
19,244 $3.24 Million
Q4 2022

Feb 10, 2023
BUY
$162.42 - $220.56 $637,011 - $865,036
3,922 Added 11.39%
38,362 $6.5 Million
Q4 2022

Feb 09, 2023
SELL
$162.42 - $220.56 $13.3 Million - $18 Million
-81,693 Reduced 70.34%
34,440 $5.83 Million
Q3 2022

Nov 02, 2022
BUY
$160.42 - $256.21 $13.8 Million - $22.1 Million
86,148 Added 287.3%
116,133 $21.7 Million
Q2 2022

Aug 01, 2022
SELL
$140.68 - $188.02 $236,483 - $316,061
-1,681 Reduced 5.31%
29,985 $4.87 Million
Q1 2022

May 04, 2022
SELL
$161.19 - $257.96 $222,442 - $355,984
-1,380 Reduced 4.18%
31,666 $4.98 Million
Q4 2021

Feb 07, 2022
SELL
$247.59 - $304.47 $355,291 - $436,914
-1,435 Reduced 4.16%
33,046 $8.75 Million
Q3 2021

Nov 02, 2021
BUY
$194.77 - $324.21 $1.91 Million - $3.18 Million
9,808 Added 39.75%
34,481 $9.97 Million
Q2 2021

Aug 03, 2021
SELL
$165.87 - $220.95 $144,804 - $192,889
-873 Reduced 3.42%
24,673 $4.93 Million
Q1 2021

May 04, 2021
SELL
$180.37 - $226.26 $1.28 Million - $1.6 Million
-7,085 Reduced 21.71%
25,546 $4.97 Million
Q4 2020

Feb 01, 2021
SELL
$148.08 - $206.57 $691,681 - $964,888
-4,671 Reduced 12.52%
32,631 $6.25 Million
Q3 2020

Nov 09, 2020
BUY
$122.51 - $158.27 $1.5 Million - $1.94 Million
12,267 Added 49.0%
37,302 $5.5 Million
Q2 2020

Aug 07, 2020
SELL
$94.33 - $140.48 $108,196 - $161,130
-1,147 Reduced 4.38%
25,035 $3.1 Million
Q1 2020

May 04, 2020
SELL
$84.96 - $109.14 $1.08 Million - $1.39 Million
-12,707 Reduced 32.68%
26,182 $2.53 Million
Q4 2019

Feb 06, 2020
BUY
$73.84 - $93.08 $1.01 Million - $1.27 Million
13,654 Added 54.11%
38,889 $3.6 Million
Q4 2019

Feb 04, 2020
SELL
$73.84 - $93.08 $805,003 - $1.01 Million
-10,902 Reduced 30.17%
25,235 $2.53 Million
Q3 2019

Nov 12, 2019
BUY
$76.65 - $95.51 $2.65 Million - $3.3 Million
34,538 Added 2159.97%
36,137 $2.77 Million
Q2 2019

Aug 15, 2019
SELL
$54.2 - $85.95 $150,784 - $239,112
-2,782 Reduced 63.5%
1,599 $137,000
Q1 2019

May 03, 2019
SELL
$49.45 - $62.8 $321,029 - $407,697
-6,492 Reduced 59.71%
4,381 $259,000
Q4 2018

Feb 05, 2019
BUY
$48.26 - $68.88 $20,365 - $29,067
422 Added 4.04%
10,873 $573,000
Q3 2018

Nov 01, 2018
BUY
$46.8 - $58.97 $176,950 - $222,965
3,781 Added 56.69%
10,451 $580,000
Q2 2018

Aug 02, 2018
BUY
$35.26 - $47.04 $32,262 - $43,041
915 Added 15.9%
6,670 $314,000
Q1 2018

May 04, 2018
BUY
$30.92 - $37.27 $49,843 - $60,079
1,612 Added 38.91%
5,755 $208,000
Q4 2017

Feb 01, 2018
BUY
$32.53 - $38.92 $11,645 - $13,933
358 Added 9.46%
4,143 $150,000
Q3 2017

Oct 27, 2017
SELL
$36.98 - $46.06 $7,987 - $9,948
-216 Reduced 5.4%
3,785 $145,000
Q2 2017

Aug 07, 2017
BUY
N/A
4,001
4,001 $166,000

Others Institutions Holding RGEN

# of Institutions
495
Shares Held
53.9M
Call Options Held
420K
Put Options Held
85.3K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.1B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email